✦ LIBER ✦

Phase II-trial with 5-day continuous infusion of mitomycin-C in advanced inoperable NSCLC

✍ Scribed by Kampf, S.; Neuhauss, R.; Schlüter, I.; Gatzemeier, U.

Book ID: 121957833
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 138 KB
Volume: 11
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(94)94198-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continuous 5-day infusion of ifosfamide

Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II study

✍ T. Cerny; G. Martinelli; A. Goldhirsch; F. Terrier; R. Joss; M. F. Fey; K. W. Br 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 414 KB

Phase I study of continuous mitomycin-C

Phase I study of continuous mitomycin-C infusion in concomitant radiochemotherapy of primary inoperable advanced head and neck cancer

✍ Hans Christiansen; Robert M. Hermann; Andrea Hille; Heinz Schmidberger; Alexios 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 200 KB

Phase II trial of continuous-infusion ip

Phase II trial of continuous-infusion iproplatin (CHIP) and 5-fluorouracil (5-FU) in advanced colorectal carcinoma

✍ Nicholas J. Petrelli; Patrick J. Creaven; Lemuel Herrera; Arnold Mittelman 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 135 KB

A phase II trial of 5-fluorouracil, doxo

A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma

✍ Susan G. Arbuck; Yusuf Silk Md; Harold O. Douglass Jr.; Hector Nava; Youcef M. R 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

To determine the feasibility and toxicity of combining leucovorin (CF) with a 5fluorouracil(5-FU) combination chemotherapy regimen currently accepted by many as standard treatment for gastric cancer, CF (500 mg/m') was administered in combination with the Georgetown S-FU, doxorubicin, and mitomycin

A phase II study with continuous infusio

A phase II study with continuous infusion cisplatin (CDDP) plus 5-fluorouracil (5-FU) in advanced non-small cell lung cancer (NSCLC)

✍ Tsuchiya, S.; Minato, K.; Nakano, H.; Fuekl, N.; Hoshino, H.; Takise, A.; Ezawa, 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Phase II trial of topotecan as a 21-day

Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas

✍ J.P Stevenson; R.M Scher; R Kosierowski; S.C Fox; M Simmonds; K.-S Yao; F Green; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 70 KB